ONC

BeOne Medicines Ltd. · NASDAQ

$363.60USDCS band Mixed

↓ $7.27 (1.96%) Today

As of Oct 27, 11:59 AM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$41.1B
Volume
329.7K
52W High
$388.66
52W Low
$253.95
PE Ratio
62.7
Avg Vol
382.1K
As of 10/26/26
Div Yield
—
Beta
0.81
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about ONC?

Latest news

News ›

Zacks Investment Research

All You Need to Know About BeOne Medicines Ltd. - Sponsored ADR (ONC) Rating Upgrade to Strong Buy

BeOne Medicines Ltd. - Sponsored ADR (ONC) has been upgraded to a Zacks Rank #1 (Strong Buy) rating, primarily driven by upward trends in earnings estimates. Over the past three months, the Zacks Consensus Estimate for the company has increased 53.4%. The upgrade positions the stock in the top 5% of Zacks-covered stocks, suggesting potential for near-term price appreciation based on improving earnings outlook.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev